SCHEMBL7708010

SCHEMBL7708010

CC1Oc2ccc(C(C)(NC(=O)OC(C)(C)C)c3ccsc3)cc2NC1=S

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711391 0.90 SMYD3 (0.38) MAPK10
SCHEMBL7094003 0.85 ADORA2B (0.32)
SCHEMBL7089637 0.84 ALDH1A1 (0.32) MAPK10
SCHEMBL7096395 0.82 NPC1 (0.33) MAPK10
SCHEMBL7093805 0.82 NAMPT (0.36)
SCHEMBL7710854 0.80
SCHEMBL7094456 0.79 SSTR4 (0.35) MAPK10
SCHEMBL7710849 0.79 MAPK10 (0.31) MAPK10
SCHEMBL7711103 0.74 SMYD3 (0.39)
SCHEMBL7711428 0.74 PARP1 (0.39) MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed